146 related articles for article (PubMed ID: 37923782)
21. Assessment of G Protein-Coupled Oestrogen Receptor Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody.
Bubb M; Beyer AL; Dasgupta P; Kaemmerer D; Sänger J; Evert K; Wirtz RM; Schulz S; Lupp A
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563581
[TBL] [Abstract][Full Text] [Related]
22. Expression of the chemokine receptor CXCR2 in normal and neoplastic neuroendocrine cells.
Tecimer T; Dlott J; Chuntharapai A; Martin AW; Peiper SC
Arch Pathol Lab Med; 2000 Apr; 124(4):520-5. PubMed ID: 10747307
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary Carcinoids and Low-Grade Gastrointestinal Neuroendocrine Tumors Show Common MicroRNA Expression Profiles, Different from Adenocarcinomas and Small Cell Carcinomas.
Yoshimoto T; Motoi N; Yamamoto N; Nagano H; Ushijima M; Matsuura M; Okumura S; Yamaguchi T; Fukayama M; Ishikawa Y
Neuroendocrinology; 2018; 106(1):47-57. PubMed ID: 28208131
[TBL] [Abstract][Full Text] [Related]
24. hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors.
Jiang SX; Kameya T; Asamura H; Umezawa A; Sato Y; Shinada J; Kawakubo Y; Igarashi T; Nagai K; Okayasu I
Mod Pathol; 2004 Feb; 17(2):222-9. PubMed ID: 14657947
[TBL] [Abstract][Full Text] [Related]
25. PCSK2 expression in neuroendocrine tumors points to a midgut, pulmonary, or pheochromocytoma-paraganglioma origin.
Remes SM; Leijon H; Vesterinen T; Louhimo J; Pulkkinen V; Ezer S; Kere J; Haglund C; Arola J
APMIS; 2020 Nov; 128(11):563-572. PubMed ID: 32794589
[TBL] [Abstract][Full Text] [Related]
26. Expression of proton-sensing G-protein-coupled receptors in selected skin tumors.
Nassios A; Wallner S; Haferkamp S; Klingelhöffer C; Brochhausen C; Schreml S
Exp Dermatol; 2019 Jan; 28(1):66-71. PubMed ID: 30339292
[TBL] [Abstract][Full Text] [Related]
27. Intersection of the Orphan G Protein-Coupled Receptor, GPR19, with the Aging Process.
Maudsley S; Walter D; Schrauwen C; Van Loon N; Harputluoğlu İ; Lenaerts J; McDonald P
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362387
[TBL] [Abstract][Full Text] [Related]
28. Reevaluation of sst₁ somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-7.
Lupp A; Nagel F; Schulz S
Regul Pept; 2013 May; 183():1-6. PubMed ID: 23466804
[TBL] [Abstract][Full Text] [Related]
29. Immunocytochemical demonstration of intermediate filament cytoskeleton proteins in human endocrine tissues and (neuro-) endocrine tumours.
Hoefler H; Denk H; Lackinger E; Helleis G; Polak JM; Heitz PU
Virchows Arch A Pathol Anat Histopathol; 1986; 409(5):609-26. PubMed ID: 3092460
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors.
Sica G; Wagner PL; Altorki N; Port J; Lee PC; Vazquez MF; Saqi A
Arch Pathol Lab Med; 2008 Dec; 132(12):1889-95. PubMed ID: 19061285
[TBL] [Abstract][Full Text] [Related]
31. Islet-1 Is Differentially Expressed Among Neuroendocrine and Non-Neuroendocrine Tumors and Its Potential Diagnostic Implication.
Xiang Y; Malik F; Zhang PJ
Int J Surg Pathol; 2023 Oct; 31(7):1294-1301. PubMed ID: 37796752
[TBL] [Abstract][Full Text] [Related]
32. G-protein coupled receptor 19 (GPR19) knockout mice display sex-dependent metabolic dysfunction.
Mushala BAS; Xie B; Sipula IJ; Stoner MW; Thapa D; Manning JR; Bugga P; Vandevender AM; Jurczak MJ; Scott I
Sci Rep; 2023 Apr; 13(1):6134. PubMed ID: 37061564
[TBL] [Abstract][Full Text] [Related]
33. RET proto-oncogene point mutations in sporadic neuroendocrine tumors.
Komminoth P; Roth J; Muletta-Feurer S; Saremaslani P; Seelentag WK; Heitz PU
J Clin Endocrinol Metab; 1996 Jun; 81(6):2041-6. PubMed ID: 8964826
[TBL] [Abstract][Full Text] [Related]
34. Forkhead box A2 transcription factor is expressed in all types of neuroendocrine lung tumors.
Khoor A; Stahlman MT; Johnson JM; Olson SJ; Whitsett JA
Hum Pathol; 2004 May; 35(5):560-4. PubMed ID: 15138929
[TBL] [Abstract][Full Text] [Related]
35. Reassessment of sst3 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-5.
Lupp A; Nagel F; Doll C; Röcken C; Evert M; Mawrin C; Saeger W; Schulz S
Neuroendocrinology; 2012; 96(4):301-10. PubMed ID: 22414742
[TBL] [Abstract][Full Text] [Related]
36. Adropin acts in brain to inhibit water drinking: potential interaction with the orphan G protein-coupled receptor, GPR19.
Stein LM; Yosten GL; Samson WK
Am J Physiol Regul Integr Comp Physiol; 2016 Mar; 310(6):R476-80. PubMed ID: 26739651
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
Rekhtman N; Pietanza CM; Sabari J; Montecalvo J; Wang H; Habeeb O; Kadota K; Adusumilli P; Rudin CM; Ladanyi M; Travis WD; Joubert P
Mod Pathol; 2018 Jan; 31(1):111-121. PubMed ID: 28884744
[TBL] [Abstract][Full Text] [Related]
38. [Differential diagnostic value of the expression of the transcription factor PDX-1 in neuroendocrine and non-neuroendocrine tumors of the pancreas and other organs].
Gurevich LE; Proshchina AE; Voronkova IA; Ashevskaya VE; Korosteleva PA; Dolzhansky OV
Arkh Patol; 2019; 81(5):11-21. PubMed ID: 31626200
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors.
Kimura N; Pilichowska M; Date F; Kimura I; Schindler M
Clin Cancer Res; 1999 Nov; 5(11):3483-7. PubMed ID: 10589762
[TBL] [Abstract][Full Text] [Related]
40. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
